The profiling of microbiota in vaginal swab samples using 16S rRNA gene sequencing and IS-pro analysis.


Journal

BMC microbiology
ISSN: 1471-2180
Titre abrégé: BMC Microbiol
Pays: England
ID NLM: 100966981

Informations de publication

Date de publication:
31 03 2021
Historique:
received: 30 09 2020
accepted: 29 01 2021
entrez: 1 4 2021
pubmed: 2 4 2021
medline: 15 12 2021
Statut: epublish

Résumé

16S rRNA gene sequencing is currently the most common way of determining the composition of microbiota. This technique has enabled many new discoveries to be made regarding the relevance of microbiota to the health and disease of the host. However, compared to other diagnostic techniques, 16S rRNA gene sequencing is fairly costly and labor intensive, leaving room for other techniques to improve on these aspects. The current study aimed to compare the output of 16S rRNA gene sequencing to the output of the quick IS-pro analysis, using vaginal swab samples from 297 women of reproductive age. 16S rRNA gene sequencing and IS-pro analyses yielded very similar vaginal microbiome profiles, with a median Pearson's R We conclude that the results of 16S rRNA gene sequencing and IS-pro are highly comparable and that both can be used to accurately determine the vaginal microbiota composition, with the IS-pro analysis having the benefit of rapidity.

Sections du résumé

BACKGROUND
16S rRNA gene sequencing is currently the most common way of determining the composition of microbiota. This technique has enabled many new discoveries to be made regarding the relevance of microbiota to the health and disease of the host. However, compared to other diagnostic techniques, 16S rRNA gene sequencing is fairly costly and labor intensive, leaving room for other techniques to improve on these aspects.
RESULTS
The current study aimed to compare the output of 16S rRNA gene sequencing to the output of the quick IS-pro analysis, using vaginal swab samples from 297 women of reproductive age. 16S rRNA gene sequencing and IS-pro analyses yielded very similar vaginal microbiome profiles, with a median Pearson's R
CONCLUSIONS
We conclude that the results of 16S rRNA gene sequencing and IS-pro are highly comparable and that both can be used to accurately determine the vaginal microbiota composition, with the IS-pro analysis having the benefit of rapidity.

Identifiants

pubmed: 33789573
doi: 10.1186/s12866-021-02149-7
pii: 10.1186/s12866-021-02149-7
pmc: PMC8015044
doi:

Substances chimiques

RNA, Ribosomal, 16S 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100

Références

Microbiology (Reading). 1996 Jan;142 ( Pt 1):3-16
pubmed: 8581168
PLoS One. 2012;7(6):e37818
pubmed: 22719852
FASEB J. 2010 Nov;24(11):4556-64
pubmed: 20643909
J Clin Microbiol. 1991 Feb;29(2):297-301
pubmed: 1706728
Sci Rep. 2017 Nov 23;7(1):16145
pubmed: 29170495
Eur J Clin Microbiol Infect Dis. 2014 Nov;33(11):1927-36
pubmed: 24894339
Gut. 2011 May;60(5):631-7
pubmed: 21209126
Curr Biol. 2009 Jun 9;19(11):R457-9
pubmed: 19515354
BMJ. 1999 Jul 24;319(7204):220-3
pubmed: 10417083
Microbiome. 2014 Feb 24;2(1):6
pubmed: 24558975
Microb Pathog. 2019 Nov;136:103696
pubmed: 31449855
Bioinformatics. 2010 Oct 1;26(19):2460-1
pubmed: 20709691
mBio. 2015 Apr 14;6(2):
pubmed: 25873373
BJOG. 2001 May;108(5):439-50
pubmed: 11368127
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4680-7
pubmed: 20534435
J Clin Microbiol. 2016 Apr;54(4):934-43
pubmed: 26763956
Arch Gynecol Obstet. 2010 Apr;281(4):589-600
pubmed: 19967381

Auteurs

M Singer (M)

Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands.
Tubascan, Spin-off at the Department of Medical Microbiology and Infection Control, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands.

R Koedooder (R)

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Erasmus University Medical Center, Wytemaweg 12, Rotterdam, 3015 CN, The Netherlands. r.koedooder@erasmusmc.nl.

M P Bos (MP)

InBiome B.V, Amsterdam, The Netherlands.

L Poort (L)

InBiome B.V, Amsterdam, The Netherlands.

S Schoenmakers (S)

Division Obstetrics, Department of Obstetrics and Gynecology, Erasmus University Medical Centre, Rotterdam, The Netherlands.

P H M Savelkoul (PHM)

Department of Medical Microbiology, Maastricht University Medical Center, Maastricht, the Netherlands.
Department of Medical Microbiology and Infection Control, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands.

J S E Laven (JSE)

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Erasmus University Medical Center, Wytemaweg 12, Rotterdam, 3015 CN, The Netherlands.

J D de Jonge (JD)

ARTPred B.V, Seringenstraat 15, 's Hertogenbosch, 5213 GS, The Netherlands.

S A Morré (SA)

Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands.
Institute of Public Health Genomics, Department of Genetics and Cell Biology, Research Institute GROW, Faculty of Health, Medicine & Life Sciences, University of Maastricht, Maastricht, The Netherlands.

A E Budding (AE)

InBiome B.V, Amsterdam, The Netherlands.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH